why aren't all 9 resolved? a statement only gets an assessment when the public
record can support or contradict it. opinions and what-ifs never can, and 0 checkable
ones are still open, waiting for their date. predictions held up or didn't;
assertions are supported or contradicted. on every card:
▮▮▮▮▮ certainty ·
▮▮▮▮▮ debate potential. speakers are clickable
Opinion
Sadeghi: 23andMe's genetic testing is ineffective for disease risk assessment
“Toilet meat technology missing millions and millions of genetic markers. Effectively, it's not actually useful for any really disease risk assessment.”
Opinion
Sadeghi: 23andMe cannot develop drugs using microarray genetic data
“They really viewed data gathering as a means to make drugs, but because it's such a small sliver of your DNA, you actually can't really make drugs off of it”
Assertion Supported
Sadeghi: 23andMe is not HIPAA compliant
“One of the most shocking things about 23 means is it's actually not HIPAA compliant, right? It doesn't follow the gold standard clinical regulations that ensure your data is safeguarded.”
Prediction Not checkable as stated
Sadeghi predicts a whole-genome consumer health behemoth within a decade
“I really do think in the next decade, You're going to see the rise of a consumer health behemoth, and that consumer health behemoth is going to have a whole genome, the entire of someone's DNA at its foundation, and it's going to impact not just someone's heal…”
Opinion
Sadeghi: Nucleus Genomics Is Years Ahead in Replacing 23andMe
“You go from Blockbuster to Netflix, you go from, you know, Blackberry to the iPhone, you go from MySpace to Facebook, and now you're going from 23 and Me to Nucleus Genomics, right? The industry is wide open, Nucleus is years ahead, and we're going to seize th…”
Disclosure
Sadeghi: Nucleus Genomics is exploring an acquisition of 23andMe assets
“I think one thing this nucleus actively is looking into right now, considering whether it makes sense, you know, earlier, I'm sure you remember, you know, we explored the possibility of acquiring and we're looking into right now whether that would make sense t…”
Assertion Supported
Sadeghi: Height has the best polygenic predictor in genomics today
“Even though the best predictor we have today, actually in the world, the best polygenic predictor is for height.”
Disclosure
Nucleus plans platform expansion into blood, wearables, and full-body MRIs
“And then also we want to continue to build up that platform beyond just genetics, blood, wearables, URI analysis, full body MRIs, and beyond into a true consumer health application.”
Disclosure
Sadeghi: Major Nucleus investors are inquiring about bidding on 23andMe
“Some of our big boy investors is in my, you know, they currently text me saying, what can we do here?”